TOBI (tobramycin) ( DrugBank: Tobramycin )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01953367 (ClinicalTrials.gov)	September 2013	4/9/2013	Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects	Bioequivalence and Safety Study of Vantobra and TOBI Nebulizer Solutions in Healthy Subjects	Cystic Fibrosis	Drug: Vantobra (tobramycin);Drug: TOBI (tobramycin)	Pari Pharma GmbH	NULL	Completed	18 Years	50 Years	Both	72	Phase 1	Germany